Skip to main content

Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells

Research Abstract

Abstract: Breast cancer is the most widespread cancer in women with rising incidence, prevalence, and mortality in developed regions. Most breast cancers (80%) are estrogen receptor–positive, indicating that disease progression could be controlled by estrogen inhibition in the breast tissue. However, drug resistance limits the benefits of this approach. Combinatorial treatment could overcome the resistance and improve the outcome of breast cancer treatment. In the current study, we prepared letrozole-(LTZSPs) and quercetin-loaded spanlastics (QuSPs) using different edge activators—Tween 80, Brij 35, and Cremophor RH40—with different concentrations. The spanlastics were evaluated for their average particles size, surface charge, and percent encapsulation efficiency. The optimized formulations were further examined using transmission electron microscopy, Fourier transform infrared spectroscopy, in vitro drug release and ex vivo skin permeation studies. The prepared spherical LTZSPs and QuSPs had average particle sizes ranged between 129–310 nm and 240–560 nm, respectively, with negative surface charge and high LTZ and Qu encapsulation (94.3–97.2% and 97.9–99.6%, respectively). The in vitro release study of LTZ and Qu from the selected formulations showed a sustained drug release for 24 h with reasonable flux and permeation through the rat skin. Further, we evaluated the in vitro cytotoxicity, cell cycle analysis, and intracellular reactive oxygen species (ROS) of the combination therapy of letrozole and quercetin either in soluble form or loaded in spanlastics against MCF-7 breast cancer cells. The LTZSPs and QuSPs combination was superior to the individual treatments and the soluble free drugs in terms of in vitro cytotoxicity, cell cycle analysis, and ROS studies. These results confirm the potential of LTZSPs and QuSPs combination for transdermal delivery of drugs for enhanced breast cancer management.

Research Authors
Aml I. Mekkawy , Nermin E. Eleraky , Ghareb M. Soliman , Mohamed G. Elnaggar and Marwa G. Elnaggar
Research Date
Research Department
Research Journal
Pharmaceutics
Research Publisher
MDPI
Research Vol
Pharmaceutics 2022, 14, 1727.
Research Website
https://www.mdpi.com/1999-4923/14/8/1727
Research Year
2022

Total-Body 18F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations

Research Abstract

Autoimmune inflammatory arthritides (AIA), such as psoriatic arthritis and rheumatoid arthritis, are chronic systemic conditions that affect multiple joints of the body. Recently, total-body (TB) PET/CT scanners exhibiting superior technical characteristics (total-body coverage, geometric sensitivity) that could benefit AIA evaluation, compared with conventional PET/CT systems, have become available. The objectives of this work were to assess the performance of an ultra-low-dose, 18F-FDG TB PET/CT acquisition protocol for evaluating systemic joint involvement in AIA and to report the association of TB PET/CT measures with joint-by-joint rheumatologic examination and standardized rheumatologic outcome measures. Methods: Thirty participants (24 with AIA and 6 with osteoarthritis) were prospectively enrolled in this single-center, observational study. All participants underwent a TB PET/CT scan for 20 min starting at 40 min after intravenous injection of 78.1 ± 4.7 MBq of 18F-FDG. Qualitative and quantitative evaluation of 18F-FDG uptake and joint involvement were performed from the resulting images and compared with the rheumatologic assessments. Results: TB PET/CT enabled the visualization of 18F-FDG uptake at joints of the entire body, including those of the hands and feet, in a single bed position, and in the same phase of radiotracer uptake. A range of pathologies consistent with AIA (and non-AIA in the osteoarthritis group) were visualized, and the feasibility of extracting PET measures from joints examined by rheumatologic assessments was demonstrated. Of 1,997 evaluable joints, there was concordance between TB PET qualitative assessments and joint-by-joint rheumatologic evaluation in the AIA and non-AIA cohorts for 69.9% and 91.1% joints, respectively, and an additional 20.1% and 8.8% joints, respectively, deemed negative on rheumatologic examination showed PET positivity. On the other hand, 10.0% and 0% joints in the AIA and non-AIA cohorts, respectively, were positive on rheumatologic evaluation but negative on TB PET. Quantitative measures from TB PET in the AIA cohort demonstrated a moderate-to-strong correlation (Spearman ρ = 0.53-0.70, P < 0.05) with the rheumatologic outcome measures. Conclusion: Systemic joint evaluation in AIA (and non-AIA) is feasible with a TB PET/CT system and an ultra-low-dose protocol. Our results provide the foundation for future larger studies to evaluate the possible improvements in AIA joint assessment via the TB PET/CT technology.

Research Authors
Yasser Gaber Ali Abdelhafez
Research Date
Research Journal
Journal of Nuclear Medicine
Research Member
Research Rank
Q1
Research Vol
63
Research Year
2022

Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients

Research Authors
Nivin Abdel-Azim, Lamiaa Fadel Alkilany, Zeinab Korany Hassan, Noha Gaber
Research Date
Research Department
Research Journal
Infection
Research Pages
1-9
Research Publisher
Springer Berlin Heidelberg
Research Rank
virology
Research Vol
7
Research Year
2022

Lectin-Like OLR1 3′ UTR Rs1050286 Gene Polymorphism and Plasma Oxidized-LDL in Coronary Artery Disease and Their Relation to Cardiovascular Risk and Outcomes

Research Authors
Hanan Sharaf El-Deen Mohammed, Manal Mohamed Kamal, Hala Mostafa ElBadre, Amal Hosni, Azza Abo Elfadl, Mohamed Ahmed Mostafa, Reham Ibrahim El-Mahdy
Research Date
Research Journal
Reports of Biochemistry & Molecular Biology
Research Member
Mohamed Ahmed Mohamed Mostafa
Research Pages
537-553
Research Rank
International
Research Vol
10(4)
Research Year
2022

Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt

Research Abstract

Background: Remarkable progress has been made in the treatment of pediatric acute lymphoblastic leukemia (ALL), with survival rates reaching > 80% in high-income countries. In Egypt, the outcome of treatment of ALL has been less favorable. Aim: To evaluate the clinicolaboratory characteristics in patients admitted at Sohag Cancer Center and to assess the outcome and the prognostic factors affecting it. Methods: This retrospective study included 79 pediatric ALL patients, from January 2010 to December 2014, who were treated according to modified Total therapy study XIIIB high-risk ALL of St. Jude Children's Research Hospital (SJCRH). Results: 52% were males with a median age of 6 years. 58.2% were stratified as HR, 69.6% had precursor B-ALL, 39.2% presented with total leucocytic count (TLC) (≥ 50x109/L), and 11.3% had CNS leukemia. Complete remission (CR) was achieved in 87.3%. Regarding treatment outcome, induction failure was reported in 5.1%, relapse in 24.1%, deaths in CR in 7.2%, and continuous complete remission in 59.5%. The median follow-up was 42 months, 4 years OS, EFS, and DFS were 64.1 ± 5.6, 57 ± 5.7, and 63.3 ± 5.8% respectively. TLC and bone marrow aspirate postinduction were the only significant prognostic factors affecting EFS. Conclusions: The modified TXIIIB of SJCRH was effective in improving ALL outcomes in our center, however, survival rates were much lower than internationally reported results with only initial TLC and response postinduction having a significant effect on EFS and DFS.

Research Authors
Amany M. Ali 1 , Amira M. El-Hefedy 2 , Douaa Sayed 3 . Amira M. Osman 1
Research Date
Research Department
Research File
final paper_1.pdf (186.78 KB)
Research Journal
Research in oncology
Research Member
Research Website
file:///D:/HARD%20DESK%20160%20G/Amira/researchs/Assisstant%20professor%20folder/Research%20in%20Oncology%207/final%20paper.pdf
Research Year
2022

Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial

Research Abstract

Background. Intrathecal fentanyl in spinal anesthesia improves intra- and postoperative analgesia. Dexmedetomidine
is a fascinating adjuvant with regards to neuraxial anesthesia in children experiencing surgery for abdominal malignancy.
Patients and Methods. After endorsement by the institutional reviewing board (IRB) and guardians’ written informed
consent, this research was carried out on 60 pediatric malignancy patients scheduled for major abdominal
surgery. Children were randomly distributed into three groups (20 patients each): Group C: given 2mL of bupivacaine
0.5% (0.4 mg/kg) intrathecally, injected gradually over 20 seconds. Group F: the same as group C, plus fentanyl
0.2 lg/kg. Group D: the same as group C, plus dexmedetomidine 0.2 lg/kg. Pain at zero, two, four, six, 12, 18, and
24 hours postoperatively was evaluated by Face, Legs, Activity, Crying, and Consolability (FLACC) score. First analgesic
request and postoperative unfavorable effects were recorded for 24 hours postoperatively. Results. A significant
decrease was recognized in the mean FLACC score in groups D and F at six, eight, and 12 hours postoperatively,
in contrast to group C (P0.05). First analgesic request was significantly prolonged in group D (7.6760.57 hours),
in contrast to groups F and C (5.4061.09 hours and 4.2363.27 hours, respectively, P < 0.04). Paracetamol utilization
was significantly decreased in group D (316.67628.86 mg), in contrast to group C (391.00652.00 mg, P < 0.03),
without a significant difference between group F (354.44646.67 mg) and groups D and C (P > 0.05). Conclusions.
Adding dexmedetomidine and fentanyl to intrathecal bupivacaine improved postoperative analgesia following
abdominal surgery for cancer in children, with better overall analgesia of dexmedetomidine compared with
fentanyl.
Key Words: Intrathecal; Fentanyl; Dexmedetomidine; Bupivacaine; Pediatric Major Abdominal Cancer Surgery

Research Authors
Khaled Mohamed Fares, MD,* Sahar Abdel-BakyMohamed,MD,* Ahmad Mohammad Abd El-Rahman, MD,† Rania Mohammed AbdeLemam, MD,‡ and Amira Mahmoud Mohamed Osman, MD§
Research Date
Research File
pnaa259.pdf (431.77 KB)
Research Journal
pain medicine
Research Member
Khaled Mohamed Fares Ali
Ahmed Mohamed Abdel Rahman Osman
Sahar Abdel Baky Mohamed Ahmad
Research Pages
1-8
Research Publisher
Oxford
Research Rank
0
Research Vol
0
Research Website
doi: 10.1093/pm/pnaa259
Research Year
2020

Neutropenic Fever in Pediatric Patients with Cancer in South Egypt: A Report from a Single Institute

Research Abstract

Background: Fever and neutropenia (FN) is a potentially life-threatening
complication of chemotherapy in children with cancer. Aim: Our objectives were
to describe the characteristics of episodes of FN experienced by our patients and
evaluate their outcomes and factors affecting them. Material & Methods: A
prospective observational study was conducted at Pediatric Oncology
Department, South Egypt Cancer Institute, Assiut University. All pediatric patients
≤ 18 years with either hematological or solid tumors admitted with documented
episodes of FN after receiving myelosuppressive chemotherapy were included in
this study between February 2018 and February 2020. Results: 200 episodes of
FN experienced by 125 pediatric cancer patients were included. The median age
was six years; 60% of the patients were boys. FN was more prevalent among
patients with hematological malignancies. Associated comorbidities were
reported in 10.5%. Eighty percent of episodes were stratified as high-risk, with
profound neutropenia reported in 47%. The focus of infection was documented in
82% of episodes. Blood-stream infections were 53.1% for Gram-negative and
24.4% for fungal isolates. Infection-related mortality was reported in 7% of
episodes. Diagnosis, disease status, risk stratification, presence of comorbidity,
and the grade of neutropenia significantly affected the outcome. Conclusion:
Although satisfactory therapeutic interventions for neutropenic patients with
fever, life-threatening resistant bacterial and fungal isolates were reported at high
rates that mandate calling for an urgent review of infection control policy.
Keywords: Fever, Neutropenia, Pediatric, Oncology, South Egypt

Research Authors
Heba A Sayed, Youstina Amir and Amira M Osman
Research Date
Research Department
Research File
Research Journal
INTERNATIONAL JOURNAL OF CANCER AND BIOMEDICAL RESEARCH (IJCBR)
Research Pages
47-55
Research Publisher
Egyptian Society of Cancer Research
Research Rank
1
Research Vol
6
Research Website
DOI: 1010.21608/jcbr.2022.110606.1240
Research Year
2022

Preemptive nebulized ketamine for pain control after tonsillectomy in children: randomized controlled trial

Research Abstract

Objectives: The administration of ketamine as nebulized inhalation is relatively new and studies
on nebulized ketamine are scarce. We aimed to investigate the analgesic efficacy of nebulized
ketamine (1 and 2 mg.kg−1) administered 30 min before general anesthesia in children undergoing
elective tonsillectomy in comparison with intravenous ketamine (0.5 mg.kg−1) and saline
placebo.
Methods: One hundred children aged (7---12) years were randomly allocated in four groups
(n = 25) receive; Saline Placebo (Group C), Intravenous Ketamine 0.5 mg.kg−1 (Group K-IV), Nebulized
Ketamine 1 mg.kg−1 (Group K-N1) or 2 mg.kg−1 (Group K-N2). The primary endpoint was
the total consumption of rescue analgesics in the first 24 h postoperative.
Results: The mean time to first request for rescue analgesics was prolonged in K-N1
(400.9
±
60.5 min, 95% CI 375.9---425.87) and K-N2 (455.5
±
44.6 min, 95% CI 437.1---473.9) groups
compared with Group K-IV (318.5
±
86.1 min, 95% CI 282.9---354.1) and Group C (68.3
±
21.9 min,
95% CI 59.5---77.1; p < 0.001), with a significant difference between K-N1 and K-N2 Groups
(p < 0.001). The total consumption of IV paracetamol in the first 24 h postoperative was reduced
in Group K-IV (672.6
±
272.8 mg, 95% CI 559.9---785.2), Group K-N1 (715.6
±
103.2 mg, 95% CI
590.4---840.8) and Group K-N2 (696.6
±
133.3 mg, 95% CI 558.8---834.4) compared with Control
Group (1153.8
±
312.4 mg, 95% CI 1024.8---1282.8; p < 0.001). With no difference between
intravenous and Nebulized Ketamine Groups (p = 0.312). Patients in intravenous and Nebulized
Ketamine Groups showed lower postoperative VRS scores compared with Group C (p < 0.001),
no differences between K-IV, K-N1 or K-N2 group and without significant adverse effects.

Research Authors
Hala S. Abdel-Ghaffar a, Amani H. Abdel-Wahab a,∗, Mohammed M. Roushdyb, Amira M.M. Osmanc
Research Date
Research File
Research Journal
REVISTA BRASILEIRA DE ANESTESIOLOGIA
Research Pages
350-357
Research Publisher
Elsevier Editora Ltda
Research Rank
4
Research Vol
69
Research Website
https://doi.org/10.1016/j.bjane.2019.04.005
Research Year
2019

Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute

Research Abstract

Background and objectives: Pediatric lymphoma is known to be associated with Epstein–Barr virus (EBV) infection. The objectives were to detect the frequency of EBV infection in pediatric lymphomas in our locality and to study its relationship with the clinicopathological characteristics of the patients.
Methods: In this descriptive cross-sectional study, we examined 78 consecutive cases of pediatric lymphomas for the presence of EBV in tumor cells by real-time Polymerase Chain Reaction on paraffin blocks for latent membrane protein-1 (LMP-1) over 3 years (January 2012 –January 2015). We collected data of the patients with pathology-proven primary lymphoma including age, sex, histologic subtype, and risk stratification.
Results: The most common subtype of pediatric lymphomas was NHL (52/78, 66.5%), while HL was diagnosed in 33.5%. EBV LMP-1 gene detection was found in 38.5% of HL, and 28.8% of NHL cases. EBV infection was significantly related to age, gender, and histological subtype in NHL cases; however, it was related to age only in those with HL. The overall difference in EBV LMP-1 gene detection was statistically significant regarding the age at presentation (P < 0.001).
Conclusion: The frequency of EBV infection in pediatric lymphomas in our locality is higher compared to Western countries, but it is lower than in endemic areas. Younger age at diagnosis was the most significant factor associated with EBV infection.
Keywords: Pediatrics, Epstein–Barr virus, Lymphoma, South Egypt Cancer Institute.

Research Authors
Osman AM1 , Ali AM1, Shaban SH2, Helmy EM3, Badrawy H4, Shibl A1
Research Date
Research Department
Research File
Paper (final).pdf (251.02 KB)
Research Journal
SECI oncology
Research Pages
101-107
Research Vol
1
Research Website
https://secioj.journals.ekb.eg/article_243679.html
Research Year
2022
Subscribe to